Metabolite amyloids have attracted significant attention owing to their role in a wide range of pathologies, including phenylketonuria (PKU). PKU is a genetic neurodegenerative disorder caused by deficient phenylalanine hydroxylase activity, resulting in the accumulation and aggregation of phenylalanine into amyloid fibrils. As an enzyme substitution therapy, Phenylalanine ammonia-lyase (PAL) is being explored to convert excess phenylalanine into cinnamic acid. However, the self-assembly of...
Source: PubMed - functional neurological disorder
ยทPublished 20 Nov 2026 ยทImported 21 Nov 2026
Relevancy: Not reviewed
Read the article